Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 445-910-2 | CAS number: 1388152-30-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 Jan 2002-05-Feb 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in 2002 according to OECD Method 474 and EU Annex V test B12and in accordance with GLP. Study material is well characterized.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- -
- EC Number:
- 445-910-2
- EC Name:
- -
- Cas Number:
- 1388152-30-4
- Molecular formula:
- Hill formula: C24 H32 N2 O7 Si CAS formula: C15 H20 O3 Si . C9 H12 N2 O4
- IUPAC Name:
- (1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)propyl-2-ammonium (1R, 5S)-5-(dimethylphenylsilyl)-2-(hydroxymethyl)cyclopent-2-ene-1-carboxylate
- Details on test material:
- Test material is a extremely light colored powder which was received at testing laboratory on 24 October 2001 and stored at room temperature in the dark.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: albino Cr1:CD-lTM(ICR)BR strain mice
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- At the start of the study the mice were in the weight range of 24 to 30 grams and were five to eight weeks old. Free access to mains drinking water and food was allowed throughout the study. The temperature and relative humidity were set to achieve limits of 19 to 25 C and 30 to 70% respectively. The rate of air exchange was at least 15 changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours of darkness.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Arachis oil
- Details on exposure:
- Doses of test material: 375, 750 or 1500 mg/kg were selected based on a range finding toxicity study.
- Duration of treatment / exposure:
- The mice were dosed only once and one group of mice from each dose level (375, 750 or 1500 mg/kg) were killed by cervical dislocation 24 hours following treatment and a second group dosed with 1500 mg/kg was killed after 48 hours.
- Frequency of treatment:
- Groups, each of seven mice, were dosed once only via the oral route with test material.
- Post exposure period:
- One group of mice from each dose level (375, 750 or 1500 mg/kg) were killed by cervical dislocation 24 hours following treatment and a second group dosed with 1500 mg/kg were killed after 48 hours. All animals were observed for signs of overt toxicity and death one hour after dosing and then once daily as applicable and immediately prior to termination.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
375 mg/kg
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
750 mg/kg
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
1500 mg/kg
Basis:
nominal conc.
- No. of animals per sex per dose:
- Male: 1500 mg/kg; No. of animals: 7; Sacrifice time: 48 hours
Male: 1500 mg/kg; No. of animals: 7; Sacrifice time: 24 hours
Male: 750 mg/kg; No. of animals: 7; Sacrifice time: 24 hours
Male: 375 mg/kg; No. of animals: 7; Sacrifice time: 24 hours - Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- A positve control group of five animals were dosed at 50 mg/kg using cyclophosphamide.
Two groups of severn animals were used as a vehicle control group (Arachis oil) with one group terminated 24 hours and the second 48 hours after dosing.
Examinations
- Tissues and cell types examined:
- Bone marrow from the femurs of each animal used for smears. Cell types examined for the presence of micronuclei in Polychromatic (PCE) and normochromatic (NCE) erythrocytes.
- Details of tissue and slide preparation:
- Immediately following termination, bone marrow smears were prepared from sections of the femurs from each animal and stained with May-Griinwald/Giemsa.Stained bone marrow smears were coded and examined blind using light microscopy at xlOOO magnification. The incidence of micronucleated cells per 2000 polychromatic erythrocytes (PCE- blue stained immature cells) per animal was scored. Micronuclei are normally circular in shape, although occasionally they may be oval or half-moon shaped, and have a sharp contour with even staining. In addition, the number of normochromatic erythrocytes (NCE-pink stained mature cells) associated with 1000 erythrocytes were counted; these cells were also scored for incidence of micronuclei. The ratio of polychromatic to normochromatic erythrocytes was calculated.
- Evaluation criteria:
- A comparison was made between the number of micronucleated polychromatic erythrocytes occurring in each of the test material groups and the number occurring in the corresponding vehicle control group. A positive mutagenic response was demonstrated when a statistically significant, dose-responsive, toxicologically relevant increase in the number of rnicronucleated polychromatic erythrocytes was observed for either the 24 or 48-hour kill times when compared to their corresponding control group. A positive response for bone marrow toxicity was demonstrated when the dose group mean polychromatic to normochromatic ratio was shown to be statistically significantly lower than the concurrent vehicle control group
- Statistics:
- Group means and standard deviations for the PCE/NCE ratios were calculated for the data. The data was analysed using Student's t-test (two tailed) and any significant results were confirmed using the one way analysis of variance.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 2000 mg/kg
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Range finding study: The test material showed no marked difference in its toxicity to male or female mice, it was therefore considered to be acceptable to use males only for the main study. Adequate evidence of test material toxicity was demonstrated via the oral route of administration, therefore, this was selected for use in the main study. The maximum tolerated dose (MTD) of the test material, 1500 mgkg, was selected for use in the main study, with 375 and 750 mgkg as the lower dose levels.
Toxic signs: In the range finding study, one male animal dosed orally at 2000mg/kg bw died following treatment. Clinical signs observed at and above 1000mg/kg bw in the range-finding and main studies included hunched posture, lethargy, tremors, laboured respiration and piloerection.
No statistically significant decreases in the PCE/NCE ratio were observed in the 24 or 48-hour test material dose groups when compared to their concurrent control groups. However, small dose-related decreases in PCE/NCE ratios were observed, these and the presence of clinical signs were taken to indicate that systemic absorption had occurred. There was no evidence of a significant increase in the incidence of micronucleated polychromatic erythrocytes in animals dosed with the test material when compared to the concurrent vehicle control groups. The positive control produced a marked increase in the frequency of micronucleated polychromatic erythrocytes.
Observations:
There were no premature deaths seen in any of the dose groups. Clinical signs were observed in animals dosed with the test material at 1500 mg/kg in both the 24 and 48-hour groups, these were as follows: hunched posture, lethargy and body tremors.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test material was found not to produce a significant increase in the frequency of micronuclei in polychromatic erythrocytes of mice under the conditions of the test. The test material was considered to be non-genotoxic under the conditions of the test. - Executive summary:
The study is considered valid and assigned a reliability rating of 1. Micronucleus in vivo:
No statistically significant decreases in the PCE/NCE ratio were observed in the 24- or 48 -hour test material dose groups when compared to their concurrent control groups. However, small dose-related decreases in PCE/NCE ratios were observed, these and the presence of clinical signs were taken to indicate that systemic absorption had occurred. The test material was found not to produce a significant increase in the frequency of micronuclei in polychromatic erythrocytes of mice under the conditions of the test. The test material was considered to be non-genotoxic under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.